EUDA Health EUDA 深 滬
等待開盤 10-08 09:30:00 美东时间
19.0394
-0.351
-1.81%
華盛通- 最 高20.1999
- 今 開19.1251
- 成交量 1.04万股
- 最 低 18.25
- 昨 收 19.39
- 總市值 5701.02万
- 52周最高 71.80
- 市盈率 靜 --
- 換手率 0.35%
- 52周最低 5.26
- 委 比 42.86%
- 總股本 299.43万
- 歷史最高 210.00
- 量 比 0.85
- 振 幅 10.06%
- 歷史最低 6.538
- 每 手 1
- 風險率 18.04%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多EUDA Health’s Melana International Wins SME100 Award in Singapore
EUDA Health Holdings ( ($EUDA) ) just unveiled an announcement. On August 26, 2...
08-27 04:57
EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore
EUDA Health Holdings Limited subsidiary Melana International Pte. Ltd. won the SME100 Awards 2026 Singapore, recognizing high-performing SMEs in Singapore and Southeast Asia. Melana, with 25 years in property management, oversees 31 properties in Singapore, including 5,675 residential and commercial units. The award highlights its expertise in property and strata management, compliance with Singapore's Building Maintenance and Strata Management A...
08-26 10:00
EUDA Health Signs Tri-Party MOU to Develop Next-Generation Oncology Cell Therapies
EUDA Health Holdings ( ($EUDA) ) has provided an announcement. On July 28, 2026...
07-29 04:58
EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
EUDA Health Holdings Limited (NASDAQ: EUDA) has signed a Memorandum of Understanding with GO POSB Organoids Pte Ltd and Shenzhen Innovation Immunotechnology Co., Ltd to collaborate on developing next-generation oncology cell therapies derived from induced pluripotent stem cells (iPSC) for cancer treatment and wellness. The agreement aims to strengthen EUDA's commercialization and distribution capabilities in innovative healthcare products. Alfred...
07-28 10:00
EUDA Health Launches Regenixé iPSC-derived Skin Stem Cell Secretome Mask; Regains Nasdaq Listing Compliance
EUDA holds the exclusive global distributorship rights for Helixé products, that includes but is not limited to, a next-generation immune health supplement, from Chemokine, a Singapore-based biotech company focused on
06-01 18:07
EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
EUDA Health Holdings Limited, a Singapore-based healthcare provider, initially received a notice from Nasdaq regarding its failure to meet the minimum market value requirement of $35 million over 32 consecutive business days. However, the company regained compliance on May 28, 2026, as its market value reached $35 million for ten consecutive days from May 13 to May 27, 2026. EUDA focuses on non-invasive healthcare in Singapore, Malaysia, and Chin...
06-01 10:00
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers GlucoTrack (NASDAQ:GCTK) stock increased by 39.7% to $1.02 during Wedn...
05-07 01:05
EUDA Health Holdings Receives Nasdaq Listing Notice
EUDA Health Holdings Limited ("EUDA" and the "Company") received a written notice (the "MVLS Notice") from Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") on April 23, 2026, indicating that the
04-27 18:10
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) shares moved upwards by 145.6%...
04-24 20:05
Why MaxLinear Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket
MaxLinear Inc (MXL) shares jump 34.3% in pre-market trading after reporting strong Q1 results and giving high Q2 sales guidance. Other gainers include CAST, ITOC, LABT, FCHL, INTC, WKC, PDFS, and LNAI. Losers include AIXI, SKLZ, AUUD, and EUDA.
04-24 17:20
